Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Finished Goods (2020 - 2025)

IceCure Medical (ICCM) has disclosed Finished Goods for 6 consecutive years, with $549000.0 as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 57.31% to $549000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $549000.0 through Dec 2025, up 57.31% year-over-year, with the annual reading at $549000.0 for FY2025, 57.31% up from the prior year.
  • Finished Goods for Q4 2025 was $549000.0 at IceCure Medical, up from $349000.0 in the prior quarter.
  • The five-year high for Finished Goods was $935000.0 in Q4 2022, with the low at $349000.0 in Q4 2024.
  • Average Finished Goods over 5 years is $639000.0, with a median of $568000.0 recorded in 2023.
  • The sharpest move saw Finished Goods skyrocketed 125.57% in 2021, then crashed 39.25% in 2023.
  • Over 5 years, Finished Goods stood at $794000.0 in 2021, then rose by 17.76% to $935000.0 in 2022, then crashed by 39.25% to $568000.0 in 2023, then tumbled by 38.56% to $349000.0 in 2024, then soared by 57.31% to $549000.0 in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $549000.0, $349000.0, and $568000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.